Lisa Harinstein
Biographic Data
| ID | 10879157 |
|---|---|
| NAME | Lisa Harinstein |
| GIVEN NAMES | Lisa |
| FAMILY NAME | Harinstein |
| SIGNATURE | HARINSTEIN L |
| AFFILIATIONS | Center for Drug Evaluation and Research |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
The Food and Drug Administration’s Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023
Objective. To characterize adverse event (AE) cases received by the US Food and Drug Administration (FDA) reportedly involving cannabinoid hemp products (CHPs). Methods. We searched the FDA Adverse Event Reporting System and Center for Food Safety and Applied Nutrition Adverse Event Reporting System for cases reported directly to the FDA from 2019–2023 involving CHPs, which are defined as products containing 1 or more of the following: cannabidio…
No prominent works on this page.
The Food and Drug Administration’s Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023
Objective. To characterize adverse event (AE) cases received by the US Food and Drug Administration (FDA) reportedly involving cannabinoid hemp products (CHPs). Methods. We searched the FDA Adverse Event Reporting System and Center for Food Safety and Applied Nutrition Adverse Event Reporting System for cases reported directly to the FDA from 2019–2023 involving CHPs, which are defined as products containing 1 or more of the following: cannabidio…
Administration (probate law) (1 works) · Adverse effect (1 works) · Adverse Event Reporting System (1 works) · Cannabinoid (1 works) · Cannabis (1 works) · Drug (1 works) · Drug administration (1 works) · Environmental health (1 works) · Food and drug administration (1 works) · Internal Medicine (1 works)